Tag Archives: grassley

Why Mental Health “Advocacy” Groups Aren’t Calling for Psychiatric Drug Investigation in Arizona Shooting: They’re Pharma Funded

In the wake of the Jared Loughner shooting in Arizona, we pointed out that the press seemed more interested in featuring Pharma-funded mouthpieces speculating on why Loughner wasn’t “treated” (drugged) and using this tragedy to start banging the drum for more government funding for more mental health treatment, (drugs) before even bothering to find out whether or not Loughner was, or had been, on psychiatric drugs. The logical question for anyone concerned with mental health would be; Was Loughner yet another in the long list of mass shooters already under the influence of psychiatric drugs documented to cause mania, psychosis, violence, homicidal and suicidal ideation that have resulted in 54 dead and 105 wounded in 10 such similar massacres? Isn’t that something we should know before spending billions more dollars on a pharmaceutically based mental health agenda? Shouldn’t we be investigating that instead of using this tragedy to get more funding for mental health “treatment”? So let’s just cut to the chase. The most prominent “mental health” groups using this shooting to cry out “give us billions more funding,” are themselves, funded by Pharma. Perhaps that answers the question of why despite the overwhelming evidence psychiatric drugs cause violence and even homicide, groups such as the National Alliance for Mental Illness (NAMI), which claims to be a “patient’s rights” organization for the “mentally ill”, are not calling for an investigation of what, if any role, psychiatric drugs played in this or any other mass shooting in the last 10 years, we are.

EDITORIAL: Why are doctors writing so many prescriptions?

Grassley, a member of the Senate Finance Committee, wrote to state Medicaid agencies earlier this year, asking them to list their top 10 prescribers of eight drugs commonly used in psychiatry. It may be that these doctors have good reasons for writing the most prescriptions for these drugs, such as OxyContin and Xanax, but it might also point out instances of overuse or even fraud. In Florida, for example, one physician wrote 96,685 prescriptions for mental health drugs over a 21-month period. That works out to more than 150 prescriptions a day, seven days a week, for nearly two years.

Grassley: Are high prescription rates a sign of fraud?

A Miami doctor wrote nearly 97,000 prescriptions in 18 months for mental health drugs. An Ohio physician wrote more than 100,000 prescriptions in two years. A Texas doctor wrote more than 14,000 prescriptions for the anti-anxiety drug Xanax. These alarmingly high prescriptions numbers for mental health drugs covered by Medicare and Medicaid have prompted Senator Charles Grassley (R-Iowa) to call for an investigation, the Associated Press reports.

Miami Psychiatrist Who Wrote 96,685 Prescriptions for Psychiatric Drugs in 21 Months Prompts Calls for Federal Investigation

Based on the huge numbers of prescriptions written by a Miami psychiatrist, Sen. Charles Grassley, R-Iowa, is continuing to pressure federal officials to investigate why some doctors write stunning numbers of scripts for tax-funded Medicare and Medicaid programs. In his latest volley, a letter sent Wednesday to Kathleen Sebelius, secretary for the U.S. Department of Health and Human Services, Grassley demanded exact answers to three pointed questions about what her department is doing to address the problem. “The federal government has an obligation to figure out what’s going on here,” Grassley said in a statement e-mailed to The Miami Herald Wednesday. “The taxpayers are footing the bill, and Medicare and Medicaid are already strained to the limit. These programs can’t spare a dollar for prescription drugs that aren’t properly prescribed.

$28 million Pharma gave NAMI doesn’t include payments to NAMI’s 50 state chapters. Senator now demanding this data.

Grassley’s investigation shows the National Alliance on Mental Illness has received more than $28 million from pharmaceutical companies in the last four years. However, that number doesn’t include pharmaceutical contributions given to NAMI’s 50 state chapters or related foundations. Grassley is now demanding that information, according to documents obtained by Dow Jones Newswires. But more than conflict of interests are at stake.